Newly listed Everest Medicines is standing out in Hong Kong's crowded biotech space: Chairman

As Shanghai headquartered Everest Medicines becomes the latest entrant on the Hong Kong stock market, Chairman Fu Wei says the company is better positioned than its peers. He explains how the biotech firm has stayed resilient throughout the coronavirus pandemic.
Fri, Oct 9 20202:05 AM EDT